These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 7221023)

  • 1. 14C-labelling of a hypocholesterolemic agents, N-(alpha-methylbenzyl) linoleamide.
    Gomi H; Nakatsuka I; Yoshitake A
    Radioisotopes; 1980 Sep; 29(9):443-5. PubMed ID: 7221023
    [No Abstract]   [Full Text] [Related]  

  • 2. The effect of N-(alpha-methylbenzyl) linoleamide on experimental atherosclerosis in rabbits.
    Fukushima H; Toki K; Nakatani H
    J Atheroscler Res; 1969; 9(1):57-64. PubMed ID: 5779582
    [No Abstract]   [Full Text] [Related]  

  • 3. The effect of N-(alpha-methylbenzyl) linoleamide on cholesterol metabolism in rats.
    Fukushima H; Aono S; Nakamura Y; Endo M; Imai T
    J Atheroscler Res; 1969; 10(3):403-14. PubMed ID: 5364088
    [No Abstract]   [Full Text] [Related]  

  • 4. Influence of N( -methylbenzyl)linoleamide upon cholesterol metabolism in rats.
    Kritchevsky D; Tepper SA
    Arzneimittelforschung; 1971 Jul; 21(7):1024-6. PubMed ID: 5109487
    [No Abstract]   [Full Text] [Related]  

  • 5. Cholesterol-lowering effects of DL-N-(alpha-methylbenzyl)-linoleamide and its optically active isomers in cholesterol-fed animals.
    Fukushima H; Nakatani H
    J Atheroscler Res; 1969; 9(1):65-71. PubMed ID: 5779584
    [No Abstract]   [Full Text] [Related]  

  • 6. Metabolism of linoleamides. I. Absorption, excretion and metabolism of N-(alpha-methylbenzyl)linoleamide in rat and man.
    Hirohashi A; Nagata A; Miyawaki H; Nakatani H; Toki K
    Xenobiotica; 1976 Jun; 6(6):329-37. PubMed ID: 969560
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cholesterol-lowering effect of N-(alpha-methylbenzyl)linoleamide (melinamide) in cholesterol-fed diabetic rats.
    Matsubara K; Matsuzawa Y; Jiao S; Kihara S; Takama T; Nakamura T; Tokunaga K; Kubo M; Tarui S
    Atherosclerosis; 1988 Aug; 72(2-3):199-204. PubMed ID: 3214468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cholesterol esterification in vitro with DL-N-(alpha-methylbenzyl)-(1-14C)linoleamide.
    Abdulla YH; Adams CW
    Atherosclerosis; 1971; 13(1):61-5. PubMed ID: 5548455
    [No Abstract]   [Full Text] [Related]  

  • 9. Influence of N-cyclohexyl linoleamide on cholesterol synthesis by rat liver slices.
    Kritchevsky D; Tepper SA
    Can J Biochem; 1968 Nov; 46(11):1429-30. PubMed ID: 5687075
    [No Abstract]   [Full Text] [Related]  

  • 10. The effect of (--)N-(alpha-phenyl-beta-(p-tolyl)ethyl) linoleamide on experimental atherosclerosis in rabbits.
    Nakatani H; Aono S; Suzuki Y; Fukushima H; Nakamura Y
    Atherosclerosis; 1970; 12(2):307-11. PubMed ID: 5493099
    [No Abstract]   [Full Text] [Related]  

  • 11. Enzymatic hydrolysis of N-(alpha-methylbenzyl)linoleamide.
    Nagata A; Miyawaki H; Endo M; Nakatani H
    Chem Pharm Bull (Tokyo); 1971 Jun; 19(6):1276-7. PubMed ID: 5557572
    [No Abstract]   [Full Text] [Related]  

  • 12. A simple method for the preparation of phosphatidylcholine labelled at 2-acyl position.
    Connor AM; Brimble PD; Choy PC
    Prep Biochem; 1981; 11(1):91-7. PubMed ID: 7220494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 14C-labelling of butylated hydroxytoluene (BHT).
    Yoshitake A; Shono F; Nakatsuka I
    Radioisotopes; 1979 Mar; 28(3):169-70. PubMed ID: 554177
    [No Abstract]   [Full Text] [Related]  

  • 14. 14C-labelling of a new beta-adrenergic blocking agent (S-596).
    Yoshitake A; Gomi H; Nakatsuka I
    Radioisotopes; 1982 Feb; 31(2):101-3. PubMed ID: 6178135
    [No Abstract]   [Full Text] [Related]  

  • 15. Double labelling of platelets with 51chromium and 14C-serotonin.
    Radegran K
    Thromb Res; 1976 May; 8(5):579-86. PubMed ID: 936103
    [No Abstract]   [Full Text] [Related]  

  • 16. Inhibitory effect of melinamide on cholesterol solubility in mixed micellar solution of sodium taurocholate.
    Nakajima T; Natori K; Hirohashi T; Aono S
    Chem Pharm Bull (Tokyo); 1986 Oct; 34(10):4273-9. PubMed ID: 3829159
    [No Abstract]   [Full Text] [Related]  

  • 17. 14C-labeling of bromobutide, 2-bromo-3,3-dimethyl-N-(alpha, alpha-dimethylbenzyl)butyramide.
    Kanamaru H; Nishioka K; Komori H; Kawahara K
    Radioisotopes; 1988 Jan; 37(1):1-6. PubMed ID: 3375464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preparation of 14C-gossypol by incorporation of acetate-1-14C and acetate-2-14C by biosynthesis.
    Smith FH
    J Am Oil Chem Soc; 1974 Sep; 51(9):410-2. PubMed ID: 4415176
    [No Abstract]   [Full Text] [Related]  

  • 19. Pilot study of labelling bovine muscle tissue with 14C.
    Cooper EL; Rao RR
    Sci Total Environ; 1995 Dec; 173-174():275-82. PubMed ID: 8560224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Labelling of lymphocytes with various radiosotopes for in vivo tracer studies; a review.
    van Rooijen N
    J Immunol Methods; 1977; 15(3):267-77. PubMed ID: 323364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.